Wells Fargo & Company Organovo Holdings, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 397 shares of ONVO stock, worth $158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

397

Previous 402 1.24%

Holding current value

$158

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.43 - $0.76 $2 - $3	-5 Reduced 1.24%	397 $0
Q2 2024 Aug 13, 2024	SELL	$0.75 - $1.35 $14 - $25	-19 Reduced 4.51%	402 $0
Q1 2024 May 10, 2024	BUY	$0.9 - $1.17 $9 - $12	11 Added 2.68%	421 $0
Q4 2023 Feb 09, 2024	SELL	$1.05 - $1.84 $527 - $923	-502 Reduced 55.04%	410 $0
Q3 2023 Nov 13, 2023	BUY	$1.06 - $1.9 $531 - $951	501 Added 121.9%	912 $1,000
Q2 2023 Aug 15, 2023	BUY	$1.64 - $2.24 $4 - $6	3 Added 0.74%	411 $0
Q1 2023 May 12, 2023	SELL	$1.44 - $3.2 $31 - $70	-22 Reduced 5.12%	408 $0
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.17 $9 - $15	7 Added 1.65%	430 $0
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.55 $528 - $1,065	-300 Reduced 41.49%	423 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.71 - $3.71 $519 - $1,127	304 Added 72.55%	723 $2,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.41 $627 - $1,009	-229 Reduced 35.34%	419 $1,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.86 $733 - $1,385	202 Added 45.29%	648 $2,000
Q3 2021 Nov 15, 2021	BUY	$6.08 - $8.92 $42 - $62	7 Added 1.59%	446 $3,000
Q2 2021 Aug 16, 2021	SELL	$6.65 - $9.95 $99 - $149	-15 Reduced 3.3%	439 $4,000
Q1 2021 May 13, 2021	SELL	$8.67 - $21.7 $286 - $716	-33 Reduced 6.78%	454 $4,000
Q4 2020 Feb 09, 2021	BUY	$7.19 - $17.05 $28 - $68	4 Added 0.83%	487 $6,000
Q3 2020 Nov 05, 2020	BUY	$6.27 - $15.8 $3,028 - $7,631	483 New	483 $4,000

Others Institutions Holding ONVO

# of Institutions

Shares Held

2.44M

Call Options Held

17K

Put Options Held

View Full List

About ORGANOVO HOLDINGS, INC.

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.48M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

More about ONVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Organovo Holdings, Inc. Transaction History